QIAGEN powered by
HGMD 2020.1 Release

QIAGEN Digital Insights Tuesday, March 31, 2020

The Spring 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

HGMD 2019.4 Release

supreme supreme Wednesday, January 15, 2020

The Winter 2019 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

HGMD Professional 2019.3 Release

QIAGEN Digital Insights Friday, September 27, 2019

More mutations, better annotations The Fall 2019 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the…

Using liquid biopsy to guide clinical trial enrollment for patients with cancer

QIAGEN Digital Insights Monday, July 8, 2019

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

Discover more disease-causing mutations with HGMD Summer ’19 release

QIAGEN Digital Insights Wednesday, June 26, 2019

  We are happy to announce the Summer ’19 Release of the Human Gene Mutation Database (HGMD) Professional is now…

QIAGEN Clinical Insight surpasses 1 million patient test cases analyzed and interpreted

QIAGEN Digital Insights Friday, June 21, 2019

We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over…

Lab performing expanded carrier screening boosts efficiency by 80%

QIAGEN Digital Insights Saturday, June 1, 2019

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…

How to accurately quantify miRNAs and increase fraction of annotated reads

Leif Schauser Tuesday, May 21, 2019

Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…

HGMD 2019.1 hits major milestone

QIAGEN Digital Insights Wednesday, April 3, 2019

Over a quarter million germline mutations catalogued HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD contains…

New momentum for harmonizing TMB results

QIAGEN Digital Insights Monday, February 4, 2019

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…

QIAGEN Conversations

QIAGEN Digital Insights Sunday, February 3, 2019

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

Driving real-world impact with N-of-One, now a QIAGEN company

QIAGEN Digital Insights Wednesday, January 30, 2019

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…